Skip to main content

Table 4 The distribution of patients according to durations of chemotherapy and TNM stages

From: The association between the duration of fluoropyrimidine-based adjuvant chemotherapy and survival in stage II or III gastric cancer

Stage (TNM)

Durations of chemotherapy

<6 M

6~12 M

12~24 M

>24 M

IIA

25 (17.0 %)

13 (13.8 %)

46 (33.0 %)

18 (36.0 %)

IIB

21 (14.3 %)

21 (22.3 %)

34 (24.4 %)

13 (26.0 %)

IIIA

24 (16.3 %)

14 (14.9 %)

22 (15.8 %)

7 (14.0 %)

IIIB

39 (26.5 %)

21 (22.3 %)

23 (16.5 %)

9 (18.0 %)

IIIC

38 (25.9 %)

25 (26.6 %)

14 (10.0 %)

3 (6.0 %)

  1. Numbers in parenthesis represent the row percentages
  2. M months